Britain's health regulator approves Pfizer/BioNTech COVID vaccine for infants

Follow us on Google News:

LONDON (Reuters) - Britain's health regulator on Tuesday authorised the use of a version of a COVID-19 vaccine made by Pfizer and BioNTech in infants and children aged 6 months to 4 years.

Whether the vaccine is eventually deployed in this age group depends on a recommendation from the UK's Joint Committee on Vaccination and Immunisation (JCVI), which advises on which shots are used as part of the national vaccination programme.

The endorsement from the Medicines and Healthcare products Regulatory Agency (MHRA) is based on data from an ongoing clinical trial involving 4,526 participants.

(Reporting by Natalie Grover in London; Editing by Jan Harvey)


The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Featured Articles